While TEX11 and HMGN5 were commonly upregulated in cisplatin-resistant patient-derived TGCT-PDC-R and cell line-derived NEC8-R cells, it remains to be elucidated whether the difference of gene expression profiles in these cells is individually associated with chemoresistance and tumor aggressiveness. Here, DECR2 is linked to neoplasm.